Patients were screened for creatinine phosphokinase (CPK) levels, and molecular genetic tests for DMD/BMD in male patients and enzyme analysis for PD in male and female patients with elevated CPK levels were performed. This evidence concerns the gene PIK3C2A and Duchenne muscular dystrophy.